KEYTRUDA is the first and only immunotherapy-based regimen to show a statistically significant and clinically meaningful improvement in overall survival
The conference aims to bring various stakeholders and experts in the field of healthcare and digital solutions for ensuring ‘universal access to affordable and quality healthcare’
The campaign targets 63 endemic districts across Bihar, Jharkhand, Karnataka, Odisha, Telangana, and Uttar Pradesh
The companies have initiated Phase 3 studies in patients with high-risk melanoma and non-small cell lung cancer
Acceptance based on results demonstrated a statistically significant improvement in overall survival versus chemotherapy alone in these patients
Empowering Research, Enhancing Proficiency is the theme of this year’s Homoeopathic Symposium
Decision marks the first approval in Europe for an anti-PD-1/L1 therapy in resectable NSCLC based on positive overall survival results
_256_384.jpg)
The Vice President also highlighted the importance of preventive healthcare and fitness
Delivers keynote address at the 4th convocation of AIIMS Jodhpur
Keynote -564 is the first Phase 3 trial to demonstrate superior overall survival (OS) with adjuvant therapy compared to placebo in patients with RCC
Subscribe To Our Newsletter & Stay Updated
